Tags: Third Point
Ceptaris Secures $10 Million in Series D-1 Financing
Ceptaris Therapeutics, Inc has raised $10 million through a Series D-1 private placement of preferred stock.
Ceptaris Therapeutics, Inc has raised $10 million through a Series D-1 private placement of preferred stock.